was read the article
array:24 [ "pii" => "S2173509315000835" "issn" => "21735093" "doi" => "10.1016/j.endoen.2015.06.005" "estado" => "S300" "fechaPublicacion" => "2015-06-01" "aid" => "684" "copyright" => "SEEN" "copyrightAnyo" => "2014" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Endocrinol Nutr. 2015;62:285-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 3296 "formatos" => array:3 [ "EPUB" => 18 "HTML" => 2687 "PDF" => 591 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1575092215000947" "issn" => "15750922" "doi" => "10.1016/j.endonu.2015.03.008" "estado" => "S300" "fechaPublicacion" => "2015-06-01" "aid" => "684" "copyright" => "SEEN" "documento" => "article" "crossmark" => 1 "subdocumento" => "ssu" "cita" => "Endocrinol Nutr. 2015;62:285-9" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 9261 "formatos" => array:3 [ "EPUB" => 22 "HTML" => 7063 "PDF" => 2176 ] ] "es" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Revisión breve</span>" "titulo" => "Hepatopatía asociada a nutrición parenteral y emulsiones lipídicas" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "285" "paginaFinal" => "289" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Parenteral nutrition-associated liver disease and lipid emulsions" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Ana Zugasti Murillo, Estrella Petrina Jáuregui, Javier Elizondo Armendáriz" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Ana" "apellidos" => "Zugasti Murillo" ] 1 => array:2 [ "nombre" => "Estrella" "apellidos" => "Petrina Jáuregui" ] 2 => array:2 [ "nombre" => "Javier" "apellidos" => "Elizondo Armendáriz" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2173509315000835" "doi" => "10.1016/j.endoen.2015.06.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509315000835?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1575092215000947?idApp=UINPBA00004N" "url" => "/15750922/0000006200000006/v1_201506250109/S1575092215000947/v1_201506250109/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2173509315000781" "issn" => "21735093" "doi" => "10.1016/j.endoen.2015.01.004" "estado" => "S300" "fechaPublicacion" => "2015-06-01" "aid" => "664" "copyright" => "SEEN" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Endocrinol Nutr. 2015;62:290-1" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1709 "formatos" => array:3 [ "EPUB" => 14 "HTML" => 1390 "PDF" => 305 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Secondary hypokalemic paralysis in adult with hypertension" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "290" "paginaFinal" => "291" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Parálisis hipopotasémica secundaria en adulto con hipertensión" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Olga Simó Guerrero, Inmaculada Cañas Alcántara, M. Asunción Recasens Gracia, Gabriel Giménez-Pérez, Ignasi Castells Fuste" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Olga" "apellidos" => "Simó Guerrero" ] 1 => array:2 [ "nombre" => "Inmaculada" "apellidos" => "Cañas Alcántara" ] 2 => array:2 [ "nombre" => "M. Asunción" "apellidos" => "Recasens Gracia" ] 3 => array:2 [ "nombre" => "Gabriel" "apellidos" => "Giménez-Pérez" ] 4 => array:2 [ "nombre" => "Ignasi" "apellidos" => "Castells Fuste" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1575092215000352" "doi" => "10.1016/j.endonu.2015.01.008" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1575092215000352?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509315000781?idApp=UINPBA00004N" "url" => "/21735093/0000006200000006/v2_201802120922/S2173509315000781/v2_201802120922/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2173509315000859" "issn" => "21735093" "doi" => "10.1016/j.endoen.2015.06.007" "estado" => "S300" "fechaPublicacion" => "2015-06-01" "aid" => "670" "copyright" => "SEEN" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "Endocrinol Nutr. 2015;62:277-84" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1399 "formatos" => array:3 [ "EPUB" => 15 "HTML" => 988 "PDF" => 396 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Clinical features, mortality, hospital admission, and length of stay of a cohort of adult patients with diabetic ketoacidosis attending the emergency room of a tertiary hospital in Spain" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "277" "paginaFinal" => "284" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Características clínicas, mortalidad, hospitalización y duración de la estancia de pacientes adultos con cetoacidosis diabética admitidos en un servicio de urgencias de un hospital terciario en España" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Pablo Guisado-Vasco, Marta Cano-Megías, Marta Carrasco-de la Fuente, Jesús Corres-González, Ana Maria Matei, Olga González-Albarrán" "autores" => array:6 [ 0 => array:2 [ "nombre" => "Pablo" "apellidos" => "Guisado-Vasco" ] 1 => array:2 [ "nombre" => "Marta" "apellidos" => "Cano-Megías" ] 2 => array:2 [ "nombre" => "Marta" "apellidos" => "Carrasco-de la Fuente" ] 3 => array:2 [ "nombre" => "Jesús" "apellidos" => "Corres-González" ] 4 => array:2 [ "nombre" => "Ana Maria" "apellidos" => "Matei" ] 5 => array:2 [ "nombre" => "Olga" "apellidos" => "González-Albarrán" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S157509221500073X" "doi" => "10.1016/j.endonu.2015.02.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S157509221500073X?idApp=UINPBA00004N" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509315000859?idApp=UINPBA00004N" "url" => "/21735093/0000006200000006/v2_201802120922/S2173509315000859/v2_201802120922/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Short review</span>" "titulo" => "Parenteral nutrition-associated liver disease and lipid emulsions" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "285" "paginaFinal" => "289" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Ana Zugasti Murillo, Estrella Petrina Jáuregui, Javier Elizondo Armendáriz" "autores" => array:3 [ 0 => array:4 [ "nombre" => "Ana" "apellidos" => "Zugasti Murillo" "email" => array:1 [ 0 => "ana.zugasti.murillo@cfnavarra.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Estrella" "apellidos" => "Petrina Jáuregui" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 2 => array:3 [ "nombre" => "Javier" "apellidos" => "Elizondo Armendáriz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Sección de Nutrición Clínica y Dietética, Complejo Hospitalario de Navarra, Pamplona, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Farmacia, Complejo Hospitalario de Navarra, Pamplona, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hepatopatía asociada a nutrición parenteral y emulsiones lipídicas" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">The first safe lipid emulsion, still on the market, was developed in 1961 and consisted of soybean oil and egg lecithin. From that date, lipid emulsions became a feature of parenteral nutrition (PN). One decade later, these emulsions were combined with all the other nutrients to obtain the well known “all-in-one” admixtures currently used.</p><p id="par0010" class="elsevierStylePara elsevierViewall">The latest generation of these emulsions includes formulas enriched with fish oil, based on omega-3 fatty acids (W3FA), and with a lower concentration of omega-6 fatty acids (W6FA), the main component of the original emulsions.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The traditional management of PN-associated liver disease (PNALD) includes the cyclic administration of PN for as short a time as possible, the early detection and treatment of catheter sepsis, the start of enteral nutrition as early as possible, the administration of ursodeoxycholic acid to decrease bile viscosity and antibiotics to prevent bacterial overgrowth, and an adequate provision of macronutrients and macronutrients in PN.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Data in the literature suggest that nutritional supplementation with fish oil may modify the inflammatory response, and some authors have reported positive results with the use of lipid emulsions with a high W3FA content in the treatment of PNALD in both children and adults.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Liver changes associated with parenteral nutrition</span><p id="par0025" class="elsevierStylePara elsevierViewall">The administration of PN has been associated with liver changes such as steatosis, steatohepatitis, fibrosis, cirrhosis, and biliary changes such as cholestasis, cholelithiasis, and cholecystitis.<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">1,2</span></a> These changes may occur in 25–100% of adult patients who receive PN.<a class="elsevierStyleCrossRef" href="#bib0170"><span class="elsevierStyleSup">3</span></a> In Spanish studies, the prevalence of such changes has been reported as 30% in critically ill patients with PN, and as 36% in patients on home PN.<a class="elsevierStyleCrossRef" href="#bib0175"><span class="elsevierStyleSup">4</span></a> If liver involvement progresses, it may lead to cirrhosis and liver and bowel transplant may be required.</p><p id="par0030" class="elsevierStylePara elsevierViewall">Diagnosis is mainly based on bilirubin and liver enzyme levels, although the cut-off points for these markers may change depending on the hospital or in different studies.<a class="elsevierStyleCrossRef" href="#bib0180"><span class="elsevierStyleSup">5</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">Moreover, the correlation between changes in these laboratory tests and histopathological findings in liver biopsies is low.<a class="elsevierStyleCrossRef" href="#bib0165"><span class="elsevierStyleSup">2</span></a> The etiology of changes has not been fully elucidated, and is thought to be multifactorial.<a class="elsevierStyleCrossRefs" href="#bib0160"><span class="elsevierStyleSup">1,6</span></a> Changes have been related to factors associated with both PN itself, such as therapy duration, calorie overload, carbohydrate overload, amino acid overload or deficiency, carnitine, choline, or taurine deficiency, excess manganese and copper administration, and continuous infusion, and to patient-associated factors such as underlying disease, sepsis, intestinal bacterial overgrowth, the presence of short bowel syndrome, a lack of enteral stimulation, or hyperinsulinism.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">3,6</span></a></p><p id="par0040" class="elsevierStylePara elsevierViewall">As regards lipids in PN, four factors have been related to liver dysfunction:<ul class="elsevierStyleList" id="lis0005"><li class="elsevierStyleListItem" id="lsti0005"><span class="elsevierStyleLabel">-</span><p id="par0045" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Lipid dose</span>: both a deficiency and an excess provision of essential fatty acids may cause liver damage. A lipid dose >1<span class="elsevierStyleHsp" style=""></span>g/kg/day is associated with a marked increase in liver changes and a 2–5 times greater risk of experiencing some severe change in the liver,<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">3,6</span></a> and has been included in current European guidelines as the value that should not be exceeded.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">7</span></a> At least 2–4% of total calories should be administered as lineoleic acid to prevent deficiency. The ratio of calories provided by carbohydrates and lipids also appears to be important, and should not exceed 60:40 in home patients according to various recommendations.<a class="elsevierStyleCrossRef" href="#bib0190"><span class="elsevierStyleSup">7</span></a> The mechanism by which toxicity related to lipid dose occurs is not clear, but it could be changes in liver macrophages, phospholipid elimination in bile, or a blockade of liver capacity to mobilize lipids.<a class="elsevierStyleCrossRef" href="#bib0185"><span class="elsevierStyleSup">6</span></a></p></li><li class="elsevierStyleListItem" id="lsti0010"><span class="elsevierStyleLabel">-</span><p id="par0050" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Lipid composition:</span> lipid emulsions based on soybean oil, with high W6FA contents, have been associated with greater liver toxicity, particularly when they are used over a long period of time.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">3,6,7</span></a> To decrease this toxicity, the alternatives proposed have included lipid emulsions with lower W6FA contents, such as those consisting of mixtures of medium (MCT) and long-chain triglycerides (LCT), those based on olive oil, those containing W3FA,<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">3,6,8</span></a> or even the provision of W3FA as the only lipid.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">9</span></a></p></li><li class="elsevierStyleListItem" id="lsti0015"><span class="elsevierStyleLabel">-</span><p id="par0055" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">Phytosterolemia</span>: lipid emulsions are mostly of plant origin and contain substantial amounts of phytosterols.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">3,6,10</span></a> These phytosterols have been related to liver toxicity in PN because they are considered to be able to alter cholesterol and bile acid production and to contribute to cholestasis.<a class="elsevierStyleCrossRefs" href="#bib0170"><span class="elsevierStyleSup">3,10</span></a></p></li><li class="elsevierStyleListItem" id="lsti0020"><span class="elsevierStyleLabel">-</span><p id="par0060" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleItalic">α-Tocoferol</span>: this may act as a potent antioxidant in cases of steatosis, protecting the liver from oxidative damage. W3FA-enriched formulas have greater amounts of α-tocoferol than those derived from soybean.</p></li></ul></p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Types of lipid emulsions (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>)</span><p id="par0065" class="elsevierStylePara elsevierViewall">To date, there have been three generations of intravenous lipid emulsions.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">11</span></a> The fatty acid profile of these emulsions has evolved with our increased understanding of their metabolism and their importance in the regulation of processes triggered by aggression and immunity (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">The first generation (based on soybean or safflower oil, Intralipid<span class="elsevierStyleSup">®</span>)</span><p id="par0070" class="elsevierStylePara elsevierViewall">These were the first lipid emulsions to be marketed (1961). Derived from soybean oil, they contain long-chain triglycerides ([LCTs] 16–18 carbon atoms) only. They were originally intended to provide essential fatty acids to prevent their deficiency, and were subsequently accepted as a concentrated source of energy.<a class="elsevierStyleCrossRef" href="#bib0210"><span class="elsevierStyleSup">11</span></a> They contain a high proportion of W6FA, approximately 50–60%, mainly as linoleic acid, an essential fatty acid. Cumulative observations of the adverse effects derived from the high proportion of W6FA in these initial lipid emulsions indicated the need to develop new emulsions having a much lower content of this type of fat.</p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">The second generation (developed to decrease the provision of W6FA in the first generation products; a mixture with medium- and long-chain triglycerides)</span><p id="par0075" class="elsevierStylePara elsevierViewall">Emulsions containing 50% of MCTs have been in clinical use since 1984. MCTs have 6–12 carbon atoms and are mainly found in coconut oil. They oxidate easily and enter mitochondria without the need for carnitine. MCTs are therefore more rapidly available for tissues than LCT emulsions and are considered immunologically neutral. As they are saturated fatty acids, they are resistant to lipid peroxidation,<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">12</span></a> do not participate in eicosanoid synthesis,<a class="elsevierStyleCrossRef" href="#bib0195"><span class="elsevierStyleSup">8</span></a> are not stored as triglycerides, and have a ketogenic effect.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">8,13,14</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Lipid emulsions based on a mixture of soybean oil and medium-chain triglycerides (Lipofundina<span class="elsevierStyleSup">®</span>)</span><p id="par0080" class="elsevierStylePara elsevierViewall">Chronologically, this emulsion appeared after the first-generation emulsions. It is a mixture of 50% soybean oil and 50% coconut or palm oil that contains a very high proportion of MCTs.<a class="elsevierStyleCrossRef" href="#bib0205"><span class="elsevierStyleSup">10</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Lipid emulsions based on soybean and olive oil (Clinoleic<span class="elsevierStyleSup">®</span>)</span><p id="par0085" class="elsevierStylePara elsevierViewall">Another solution for decreasing W6FA content was to base the emulsion on olive oil (80%), with EFA provision being completed with soybean oil (20%). This emulsion contains oleic acid as the main component, a monounsaturated acid of the omega-9 family (W9FA), and has some benefits such as resistance to lipid peroxidation, an effect that is considered neutral and poorly toxic on the immune system, and a decreased generation of pro-inflammatory cell mediators.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">8,12,13</span></a> It has also been postulated that some phenolic compounds contained in olive oil could provide additional advantages as being antioxidant and anti-inflammatory.<a class="elsevierStyleCrossRef" href="#bib0230"><span class="elsevierStyleSup">15</span></a></p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Lipid emulsions based on a chemical mixture of soybean oil and medium-chain triglycerides. Structured lipids (Structolipid<span class="elsevierStyleSup">®</span>)</span><p id="par0090" class="elsevierStylePara elsevierViewall">These are emulsions consisting of synthetic lipids obtained through the hydrolysis of soybean and coconut oils, equivalent to 64% of soybean oil and 34% of coconut oil, and subsequent random reesterification. The result is a fat that contains LCTs and MCTs in the same glycerol and in a resulting equimolecular proportion.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">8,12,16</span></a> It appears that fewer changes occur in the liver<a class="elsevierStyleCrossRef" href="#bib0240"><span class="elsevierStyleSup">17</span></a> and immune system<a class="elsevierStyleCrossRef" href="#bib0215"><span class="elsevierStyleSup">12</span></a> as compared with physical mixture or soybean emulsions.</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">The third generation</span><p id="par0095" class="elsevierStylePara elsevierViewall">This refers to the incorporation of W3FA into emulsions of a prior generation, decreasing W6FA provision, to positively modulate inflammation and immunosuppression. This generation is clearly aimed at achieving a pharmaconutrient effect.</p><p id="par0100" class="elsevierStylePara elsevierViewall">W3FA doses >0.05<span class="elsevierStyleHsp" style=""></span>g/kg/day have been reported to provide benefits, with optimal doses of 0.14–0.30<span class="elsevierStyleHsp" style=""></span>g/kg/day.<a class="elsevierStyleCrossRef" href="#bib0245"><span class="elsevierStyleSup">18</span></a> However, further studies confirming these results are needed.</p><p id="par0105" class="elsevierStylePara elsevierViewall">These emulsions are considered to be safe, and no significant adverse effects have been reported.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">8,13,19</span></a> They have even improved or reversed the toxicity of PN for the liver.<a class="elsevierStyleCrossRef" href="#bib0200"><span class="elsevierStyleSup">9</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">Two emulsions containing fish oil are currently being marketed in Spain:</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">A lipid emulsion based on soybean oil, medium-chain triglycerides, and fish oil: MSF emulsion (Lipoplus<span class="elsevierStyleSup">®</span>)</span><p id="par0115" class="elsevierStylePara elsevierViewall">This is an emulsion based on the second generation of the physical mixture of soybean oil and MCTs in which part of the soybean oil is replaced by fish oil to achieve final concentrations of 40%, 50%, and 10% respectively. This emulsion has been found to increase contents in eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in plasma phospholipids and erythrocyte membranes, and to the modulated production of pro-inflammatory leukotrienes<a class="elsevierStyleCrossRef" href="#bib0250"><span class="elsevierStyleSup">19</span></a> with no negative impact on gas exchange or hemodynamics.</p></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">A lipid emulsion based on soybean oil, medium-chain triglycerides, olive oil, and fish oil: SMOF emulsion (SMOFlipid<span class="elsevierStyleSup">®</span>)</span><p id="par0120" class="elsevierStylePara elsevierViewall">This is based on a physical mixture of soybean oil, MCTs, and olive and fish oils at 30%, 30%, 25%, and 15% respectively. This is a new concept of emulsion that combines the conditions of an “ideal” emulsion in the light of our current knowledge, with a balanced and more physiological fatty acid composition, and a ω-6/ω-3 ratio within the optimum range.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">8,19</span></a> This emulsion is metabolized 40% faster than soybean oil-based emulsions.</p><p id="par0125" class="elsevierStylePara elsevierViewall">Increased plasma levels of W3FA, together with decreased W6FA levels, reduce levels of pro-inflammatory mediators, have a neutral impact on inflammatory and immune variables, and have been shown in several studies to decrease both hospital stay and mortality and the number of days of mechanical ventilation in critically ill patients.<a class="elsevierStyleCrossRefs" href="#bib0195"><span class="elsevierStyleSup">8,12,13,20</span></a></p></span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Omegaven<span class="elsevierStyleSup"><span class="elsevierStyleItalic">®</span></span> (not marketed in Spain)</span><p id="par0130" class="elsevierStylePara elsevierViewall">This is a 100% ultra-refined fish oil emulsion available on the market since 1998. It is recommended that it be administered together with other lipid emulsions at a maximum dose of 1–2<span class="elsevierStyleHsp" style=""></span>mL/kg. The first case in which this product was used alone in a patient with soybean allergy to prevent EFA deficiency was reported in 2005.<a class="elsevierStyleCrossRef" href="#bib0260"><span class="elsevierStyleSup">21</span></a></p></span></span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Emulsions of omega-3 fatty acids alone and the improvement of parenteral nutrition-associated liver disease</span><p id="par0135" class="elsevierStylePara elsevierViewall">Several articles reporting PNALD improvement with the use of Omegaven<span class="elsevierStyleSup">®</span> (as a supplement of another lipid emulsion or as a single formula) in both children<a class="elsevierStyleCrossRefs" href="#bib0265"><span class="elsevierStyleSup">22–25</span></a> and adults have been published in recent years.<a class="elsevierStyleCrossRefs" href="#bib0285"><span class="elsevierStyleSup">26–30</span></a> In adult patients, liver function improvement has been seen in a short period (4–8 weeks), but no data are available beyond 16 weeks of follow-up.<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">29</span></a></p><p id="par0140" class="elsevierStylePara elsevierViewall">The patient reported by Jurewitsch et al.<a class="elsevierStyleCrossRef" href="#bib0285"><span class="elsevierStyleSup">26</span></a> initially received a mixture of soybean emulsion together with Omegaven<span class="elsevierStyleSup">®</span> (0.25<span class="elsevierStyleHsp" style=""></span>g/kg/day) for four weeks. In view of the stabilization of bilirubin levels, Omegaven<span class="elsevierStyleSup">®</span> alone was continued at the same dose as maintenance therapy, resulting in the normalization of bilirubin levels at 16 weeks, decreased hepatomegaly, and the disappearance of cholestasis in a biopsy performed five months after treatment start.</p><p id="par0145" class="elsevierStylePara elsevierViewall">Xu et al.<a class="elsevierStyleCrossRef" href="#bib0290"><span class="elsevierStyleSup">27</span></a> reported a series of 15 adults (9 females and 6 males) in which an emulsion of soybean oil and MCTs was replaced by Omegaven<span class="elsevierStyleSup">®</span> (0.15–2<span class="elsevierStyleHsp" style=""></span>g/kg/day, maximum 10<span class="elsevierStyleHsp" style=""></span>g/day) for two months. Eighty percent of the subjects experienced a normalization of esterified bilirubin levels within four weeks, as well as decreased cholestasis and inflammation at biopsies.</p><p id="par0150" class="elsevierStylePara elsevierViewall">Burns et al.<a class="elsevierStyleCrossRef" href="#bib0295"><span class="elsevierStyleSup">28</span></a> replaced an emulsion based on soybean oil only by Omegaven<span class="elsevierStyleSup">®</span> (1<span class="elsevierStyleHsp" style=""></span>g/kg 5 days weekly) in a patient, resulting in laboratory data improvement at five weeks and a normalization of bilirubin levels at eight weeks. These results persisted at 29 weeks.</p><p id="par0155" class="elsevierStylePara elsevierViewall">Venecourt et al.<a class="elsevierStyleCrossRef" href="#bib0300"><span class="elsevierStyleSup">29</span></a> reported a patient receiving an emulsion of soybean and olive oil whose bilirubin levels decreased (at 8 weeks) and whose transaminase levels normalized (at 10 weeks) after switching to Omegaven<span class="elsevierStyleSup">®</span> (1<span class="elsevierStyleHsp" style=""></span>g/kg 6 days weekly).</p><p id="par0160" class="elsevierStylePara elsevierViewall">The most recent series, reported by Pastor-Clerigues et al.,<a class="elsevierStyleCrossRef" href="#bib0305"><span class="elsevierStyleSup">30</span></a> provided data on the anti-inflammatory and antifibrotic effect of Omegaven<span class="elsevierStyleSup">®</span> administered to two patients for four months (1<span class="elsevierStyleHsp" style=""></span>g/kg 5 days weekly). Liver function impairment recurred on the replacement of this emulsion by a mixture of soybean oil, MCTs, and olive and fish oils.</p></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Conclusions</span><p id="par0165" class="elsevierStylePara elsevierViewall">Patients diagnosed with PNALD have a high mortality rate as a result of liver cirrhosis/failure if PN discontinuation or liver and bowel transplant is not possible. An understanding of all the mechanisms involved in the development of this disease and the availability of effective and safe treatments are therefore especially important. In recent years there has been an increasing interest in treatment and prevention using W3FA-enriched lipid formulas. Although the exact mechanism is unknown, it could lie in a decreased hepatic apoptosis due to the effect of EPA and DHA contained in these types of formulas, along with an essential anti-inflammatory role, and to decreased W6FA provision.</p><p id="par0170" class="elsevierStylePara elsevierViewall">Elsewhere<a class="elsevierStyleCrossRef" href="#bib0310"><span class="elsevierStyleSup">31</span></a> in this issue of the journal we report the case of a patient who was treated with W3FA alone for 50 weeks, the longest treatment with Omegaven<span class="elsevierStyleSup">®</span> reported in Spain. We believe that this case may lead to a new approach to the treatment of patients with PNALD. The improvement in the laboratory results was important, but the change in portal flow direction detected in the imaging tests was even more significant as indirect evidence of portal hypertension improvement. No deficiencies in essential fatty acids were found during the follow-up period.</p><p id="par0175" class="elsevierStylePara elsevierViewall">Larger series and longer follow-up periods will provide more information about the ideal proportions of W3FA and W6FA and the dose that should be given in PN to cover nutritional requirements and prevent hepatic complications.</p></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Conflicts of interest</span><p id="par0180" class="elsevierStylePara elsevierViewall">The authors state that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:11 [ 0 => array:3 [ "identificador" => "xres982722" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec950268" "titulo" => "Keywords" ] 2 => array:3 [ "identificador" => "xres982721" "titulo" => "Resumen" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0010" ] ] ] 3 => array:2 [ "identificador" => "xpalclavsec950267" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Liver changes associated with parenteral nutrition" ] 6 => array:3 [ "identificador" => "sec0015" "titulo" => "Types of lipid emulsions (Table 1)" "secciones" => array:9 [ 0 => array:2 [ "identificador" => "sec0020" "titulo" => "The first generation (based on soybean or safflower oil, Intralipid)" ] 1 => array:2 [ "identificador" => "sec0025" "titulo" => "The second generation (developed to decrease the provision of W6FA in the first generation products; a mixture with medium- and long-chain triglycerides)" ] 2 => array:2 [ "identificador" => "sec0030" "titulo" => "Lipid emulsions based on a mixture of soybean oil and medium-chain triglycerides (Lipofundina)" ] 3 => array:2 [ "identificador" => "sec0035" "titulo" => "Lipid emulsions based on soybean and olive oil (Clinoleic)" ] 4 => array:2 [ "identificador" => "sec0040" "titulo" => "Lipid emulsions based on a chemical mixture of soybean oil and medium-chain triglycerides. Structured lipids (Structolipid)" ] 5 => array:2 [ "identificador" => "sec0045" "titulo" => "The third generation" ] 6 => array:2 [ "identificador" => "sec0050" "titulo" => "A lipid emulsion based on soybean oil, medium-chain triglycerides, and fish oil: MSF emulsion (Lipoplus)" ] 7 => array:2 [ "identificador" => "sec0055" "titulo" => "A lipid emulsion based on soybean oil, medium-chain triglycerides, olive oil, and fish oil: SMOF emulsion (SMOFlipid)" ] 8 => array:2 [ "identificador" => "sec0060" "titulo" => "Omegaven (not marketed in Spain)" ] ] ] 7 => array:2 [ "identificador" => "sec0065" "titulo" => "Emulsions of omega-3 fatty acids alone and the improvement of parenteral nutrition-associated liver disease" ] 8 => array:2 [ "identificador" => "sec0070" "titulo" => "Conclusions" ] 9 => array:2 [ "identificador" => "sec0075" "titulo" => "Conflicts of interest" ] 10 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2014-11-24" "fechaAceptado" => "2015-03-13" "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec950268" "palabras" => array:3 [ 0 => "Parenteral nutrition-associated liver disease" 1 => "Fish oil-based lipid emulsion" 2 => "Omegaven" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec950267" "palabras" => array:3 [ 0 => "Hepatopatía asociada a nutrición parenteral" 1 => "Emulsión lipídica ácidos grasos omega-3" 2 => "Omegaven" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Parenteral nutrition-associated liver disease (PNALD) is a particularly important problem in patients who need this type of nutritional support for a long time. Prevalence of the condition is highly variable depending on the series, and its clinical presentation is different in adults and children. The etiology of PNALD is not well defined, and participation of several factors at the same time has been suggested. When a bilirubin level >2<span class="elsevierStyleHsp" style=""></span>mg/dl is detected for a long time, other causes of liver disease should be ruled out and risk factors should be minimized.</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">The composition of lipid emulsions used in parenteral nutrition is one of the factors related to PNALD. This article reviews the different types of lipid emulsions and the potential benefits of emulsions enriched with omega-3 fatty acids.</p></span>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<span id="abst0010" class="elsevierStyleSection elsevierViewall"><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">La afectación de la función hepática asociada con la nutrición parenteral es un problema especialmente importante en los pacientes que precisan este tipo de soporte nutricional durante un tiempo prolongado. La prevalencia es muy variable según las series, y se presenta clínicamente de forma distinta en adultos y en niños. Su etiología no está bien definida y se contempla la participación de varios factores al mismo tiempo. Cuando se detecta un nivel de bilirrubina > 2<span class="elsevierStyleHsp" style=""></span>mg/dl durante un período prolongado se deben descartar otras causas de hepatopatía y minimizar los factores de riesgo.</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">La composición de las emulsiones lipídicas empleadas en la nutrición parenteral es uno de los factores relacionados con la alteración de la función hepática. En este artículo se revisan los distintos tipos de emulsiones lipídicas, así como los posibles beneficios de las fórmulas enriquecidas con ácidos grasos omega-3.</p></span>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Zugasti Murillo A, Petrina Jáuregui E, Elizondo Armendáriz J. Hepatopatía asociada a nutrición parenteral y emulsiones lipídicas. Endocrinol Nutr. 2015;62:285–289.</p>" ] ] "multimedia" => array:1 [ 0 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">DHA: docosahexaenoic acid; EPA: eicosapentaenoic acid; LCTs: long-chain triglycerides; MCTs: medium-chain triglycerides; MSF: MCTs/soybean/fish; SMOF: soybean/MCTs/olive/fish.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col">Trade name \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">Intralipid<span class="elsevierStyleSup">®</span> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">Lipofundina<span class="elsevierStyleSup">®</span><br>MCTs/LCTs \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">Clinoleic<span class="elsevierStyleSup">®</span> 20% \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">Structolipid<span class="elsevierStyleSup">®</span> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">Lipoplus<span class="elsevierStyleSup">®</span> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">SMOFLipid<span class="elsevierStyleInf">®</span> \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col">Omegaven<span class="elsevierStyleSup">®</span> \t\t\t\t\t\t\n \t\t\t\t</th></tr><tr title="table-row"><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Type of emulsion \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Soybean \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Physical mixture<br>MCTs/LCTs \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Olive/soybean \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Chemical mixture<br>MCTs/LCTs \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Soybean/MCT/W3-MSF \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Soybean/MCTs/olive/W3-SMOF \t\t\t\t\t\t\n \t\t\t\t</th><th class="td" title="table-head " align="left" valign="top" scope="col" style="border-bottom: 2px solid black">Fish \t\t\t\t\t\t\n \t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleItalic">Generation</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1st \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2nd \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2nd \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2nd \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3rd \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3rd \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3rd \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " colspan="8" align="left" valign="top"><span class="elsevierStyleItalic">Oil origin (%)</span></td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Soybean \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">100 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">20 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">64 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">40 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Coconut \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">36 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">50 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Olive \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">80 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">25 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleHsp" style=""></span>Fish \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">100 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleItalic">W3 concentration (g/L)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="" valign="top"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">15.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">37.3 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleItalic">W6:W3 ratio</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7:1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7:1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">9:1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">7:1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.7:1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.5:1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1:8 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleItalic">Linoleic</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">44–62 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">27 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">18.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">35 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">25.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">21.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4.4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleItalic">α Linolenic</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4–11 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">1.8 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleItalic">α Tocoferol (mg/L)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">38 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">85<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>20 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">32 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">6.9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">190<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>30 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">200 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">150–296 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleItalic">EPA</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3.7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">19.2 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleItalic">DHA</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">12.1 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="table-entry " align="left" valign="top"><span class="elsevierStyleItalic">Phytosterols (mg/L)</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">348 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">327<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">NA \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">47.6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="table-entry " align="left" valign="top">0 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab1664101.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Characteristics of lipid emulsions.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:31 [ 0 => array:3 [ "identificador" => "bib0160" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "Doc 1. [chapter 11]" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Complications and monitoring – guidelines on parenteral nutrition" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "W.H. Hartl" 1 => "K.W. Jauch" 2 => "K. Parhofer" 3 => "P. Rittler" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3205/000067" "Revista" => array:4 [ "tituloSerie" => "Ger Med Sci" "fecha" => "2009" "volumen" => "7" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19718276" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0165" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Complicaciones hepáticas asociadas al uso de nutrición parenteral" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "J.M. Moreno Villares" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Nutr Hosp" "fecha" => "2008" "volumen" => "23" "numero" => "Suppl 2" "paginaInicial" => "25" "paginaFinal" => "33" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18714408" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0170" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Parenteral nutrition-associated liver disease in adult and pediatric patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "V.J. Kumpf" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0115426506021003279" "Revista" => array:6 [ "tituloSerie" => "Nutr Clin Pract" "fecha" => "2006" "volumen" => "21" "paginaInicial" => "279" "paginaFinal" => "290" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16772545" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0175" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Liver dysfunction associated with artificial nutrition in critically ill patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T. Grau" 1 => "A. Bonet" 2 => "M. Rubio" 3 => "D. Mateo" 4 => "M. Farre" 5 => "J.A. Acosta" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc5670" "Revista" => array:6 [ "tituloSerie" => "Crit Care" "fecha" => "2007" "volumen" => "11" "paginaInicial" => "R10" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17254321" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0010782411004720" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0180" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Development of liver dysfunction under artificial nutrition: a reason to modify nutrition therapy in the intensive care unit?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Stehle" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1186/cc5679" "Revista" => array:5 [ "tituloSerie" => "Crit Care" "fecha" => "2007" "volumen" => "11" "paginaInicial" => "112" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17316464" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0185" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Managing liver dysfunction in parenteral nutrition" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.A. Lloyd" 1 => "S.M. Gabe" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1017/S002966510700585X" "Revista" => array:7 [ "tituloSerie" => "Proc Nutr Soc" "fecha" => "2007" "volumen" => "66" "paginaInicial" => "530" "paginaFinal" => "538" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17961274" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0010782415001304" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0190" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Staun" 1 => "L. Pironi" 2 => "F. Bozzetti" 3 => "J. Baxter" 4 => "A. Forbes" 5 => "F. Joly" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.clnu.2009.04.001" "Revista" => array:6 [ "tituloSerie" => "Clin Nutr" "fecha" => "2009" "volumen" => "28" "paginaInicial" => "467" "paginaFinal" => "479" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19464089" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0195" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "New parenteral lipid emulsions for clinical use" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "D.L. Waitzberg" 1 => "R.S. Torrinhas" 2 => "T.M. Jacintho" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0148607106030004351" "Revista" => array:6 [ "tituloSerie" => "JPEN J Parenter Enteral Nutr" "fecha" => "2006" "volumen" => "30" "paginaInicial" => "351" "paginaFinal" => "367" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16804134" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0200" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fish oil-based lipid emulsions prevent and reverse parenteral nutrition associated liver disease: the Boston experience" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "V.E. De Meijer" 1 => "K.M. Gura" 2 => "H.D. Le" 3 => "J.A. Meisel" 4 => "M. Puder" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0148607109332773" "Revista" => array:6 [ "tituloSerie" => "JPEN J Parenter Enteral Nutr" "fecha" => "2009" "volumen" => "33" "paginaInicial" => "541" "paginaFinal" => "547" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19571170" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0205" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Phytosterolemia in parenteral nutrition patients: implications for liver disease development" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Llop" 1 => "N. Virgili" 2 => "J.M. Moreno-Villares" 3 => "P. Garcia-Peris" 4 => "T. Serrano" 5 => "M. Forga" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nut.2008.06.017" "Revista" => array:8 [ "tituloSerie" => "Nutrition" "fecha" => "2008" "volumen" => "24" "numero" => "11-12" "paginaInicial" => "1145" "paginaFinal" => "1152" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18656327" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0002937812003997" "estado" => "S300" "issn" => "00029378" ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0210" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Evolution of parenteral lipid emulsions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "D.L. Waitzberg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Clin Nutr Suppl" "fecha" => "2005" "volumen" => "1" "paginaInicial" => "5" "paginaFinal" => "7" ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0215" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Immune modulation by parenteral lipid emulsions" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "G.J. Wanten" 1 => "P.C. Calder" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Am J Clin Nutr" "fecha" => "2007" "volumen" => "85" "paginaInicial" => "1171" "paginaFinal" => "1184" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17490951" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0002937812001317" "estado" => "S300" "issn" => "00029378" ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0220" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hot topics in parenteral nutrition. Rationale for using new lipid emulsions in parenteral nutrition and a review of the trials performed in adults" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P.C. Calder" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1017/S0029665109001268" "Revista" => array:6 [ "tituloSerie" => "Proc Nutr Soc" "fecha" => "2009" "volumen" => "68" "paginaInicial" => "252" "paginaFinal" => "260" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19426581" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0225" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The metabolic consequences of infusing emulsions containing medium chain triglycerides for parenteral nutrition: a comparative study with conventional lipid" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.R. Dennison" 1 => "M. Ball" 2 => "P.J. Crowe" 3 => "K. White" 4 => "L. Hands" 5 => "R.M. Watkins" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Ann R Coll Surg Engl" "fecha" => "1986" "volumen" => "68" "paginaInicial" => "119" "paginaFinal" => "121" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/3089123" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0230" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Olive oil in parenteral nutrition" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Sala-Vila" 1 => "V.M. Barbosa" 2 => "P.C. Calder" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/MCO.0b013e32802bf787" "Revista" => array:6 [ "tituloSerie" => "Curr Opin Clin Nutr Metab Care" "fecha" => "2007" "volumen" => "10" "paginaInicial" => "165" "paginaFinal" => "174" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17285004" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0235" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Structured triglyceride emulsions in parenteral nutrition" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "C. Chambrier" 1 => "M. Lauverjat" 2 => "P. Bouletreau" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0115426506021004342" "Revista" => array:6 [ "tituloSerie" => "Nutr Clin Pract" "fecha" => "2006" "volumen" => "21" "paginaInicial" => "342" "paginaFinal" => "350" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16870802" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0240" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hepatocellular integrity in patients requiring parenteral nutrition: comparison of structured MCT/LCT vs. a standard MCT/LCT emulsion and a LCT emulsion" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "S.N. Piper" 1 => "K.D. Rohm" 2 => "J. Boldt" 3 => "B. Odermatt" 4 => "W.H. Maleck" 5 => "S.W. Suttner" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1017/S0265021508004055" "Revista" => array:6 [ "tituloSerie" => "Eur J Anaesthesiol" "fecha" => "2008" "volumen" => "25" "paginaInicial" => "557" "paginaFinal" => "565" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18413006" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0245" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Omega-3 fatty acids improve the diagnosis-related clinical outcome" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.R. Heller" 1 => "S. Rossler" 2 => "R.J. Litz" 3 => "S.N. Stehr" 4 => "S.C. Heller" 5 => "R. Koch" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.CCM.0000206309.83570.45" "Revista" => array:6 [ "tituloSerie" => "Crit Care Med" "fecha" => "2006" "volumen" => "34" "paginaInicial" => "972" "paginaFinal" => "979" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16484909" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0250" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Fish oil lipid emulsions and immune response: what clinicians need to know" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.L. Waitzberg" 1 => "R.S. Torrinhas" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/0884533609339071" "Revista" => array:6 [ "tituloSerie" => "Nutr Clin Pract" "fecha" => "2009" "volumen" => "24" "paginaInicial" => "487" "paginaFinal" => "499" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19605803" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0255" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Parenteral fish oil lipid emulsions in the critically ill: a systematic review and metaanalysis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "W. Manzanares" 1 => "R. Dhaliwal" 2 => "B. Jurewitsch" 3 => "R.D. Stapleton" 4 => "K.N. Jeejeeboy" 5 => "D.K. Heyland" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "JPEN" "fecha" => "2014" "volumen" => "38" "paginaInicial" => "20" "paginaFinal" => "28" ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0260" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.M. Gura" 1 => "S.K. Parsons" 2 => "L.J. Bechard" 3 => "T. Henderson" 4 => "M. Dorsey" 5 => "W. Phipatanakul" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.clnu.2005.05.020" "Revista" => array:6 [ "tituloSerie" => "Clin Nutr" "fecha" => "2005" "volumen" => "24" "paginaInicial" => "839" "paginaFinal" => "847" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16029913" "web" => "Medline" ] ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0265" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reversal of parenteral nutritiona associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "K.M. Gura" 1 => "C.P. Duggan" 2 => "S.B. Collier" 3 => "R.W. Jennings" 4 => "J. Folkman" 5 => "B.R. Bistrian" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1542/peds.2005-2662" "Revista" => array:7 [ "tituloSerie" => "Pediatrics" "fecha" => "2006" "volumen" => "118" "paginaInicial" => "e197" "paginaFinal" => "e201" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16818533" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0010782408005787" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0270" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Parenteral fish oil monotherapy in the management of patients with parenteral nutrition associated liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "V.E. De Meijer" 1 => "K.M. Gura" 2 => "J.A. Meisel" 3 => "H.D. Le" 4 => "M. Puder" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/archsurg.2010.80" "Revista" => array:6 [ "tituloSerie" => "Arch Surg" "fecha" => "2010" "volumen" => "145" "paginaInicial" => "547" "paginaFinal" => "551" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/20566974" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0275" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Use of an omega-3 fatty acide-based emulsion in the treatment of parenteral nutrition-induced cholestasis in patients with microvillous inclusion disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Fuchs" 1 => "E.M. Fallon" 2 => "K.M. Gura" 3 => "M. Puder" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jpedsurg.2011.09.061" "Revista" => array:6 [ "tituloSerie" => "J Pediatr Surg" "fecha" => "2011" "volumen" => "46" "paginaInicial" => "2376" "paginaFinal" => "2382" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22152886" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0280" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An exclusively based parenteral fish-oil emulsion reverses cholestasis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.T. Junco" 1 => "N. García" 2 => "C. Zozaya" 3 => "M. Ybarra Zabala" 4 => "S. Abrams" 5 => "A. García de Lorenzo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3305/nh.2015.31.1.8284" "Revista" => array:6 [ "tituloSerie" => "Nutr Hosp" "fecha" => "2015" "volumen" => "31" "paginaInicial" => "514" "paginaFinal" => "516" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25561149" "web" => "Medline" ] ] ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0285" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Omega 3 enriched lipid emulsion for liver salvage in parenteral nutrition induced cholestasis in the adult patient" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "B. Jurewitsch" 1 => "G. Gardiner" 2 => "M. Naccarato" 3 => "K.N. Jeejeeboy" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "JPEN" "fecha" => "2011" "volumen" => "35" "paginaInicial" => "386" "paginaFinal" => "390" ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0290" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Z. Xu" 1 => "Y. Li" 2 => "J. Wang" 3 => "B. Wu" 4 => "J. Li" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.clnu.2011.10.001" "Revista" => array:6 [ "tituloSerie" => "Clin Nutr" "fecha" => "2012" "volumen" => "31" "paginaInicial" => "217" "paginaFinal" => "223" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22035955" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0295" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Reversal of parenteral nutrition-associated liver disease with a fish oil-based lipid emulsion (Omegaven) in an adult dependent on home parenteral nutrition" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D.L. Burns" 1 => "B.M. Gill" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "JPEN" "fecha" => "2013" "volumen" => "37" "paginaInicial" => "274" "paginaFinal" => "280" ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0300" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Succesful treatment of parenteral nutrition associated liver disease in an adult by use of a fish oil-based lipid source" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "E. Venecourt-Jackson" 1 => "S.J. Hill" 2 => "R.S. Walmsley" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nut.2012.07.009" "Revista" => array:7 [ "tituloSerie" => "Nutrition" "fecha" => "2013" "volumen" => "29" "paginaInicial" => "356" "paginaFinal" => "358" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/23141119" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0010782411001016" "estado" => "S300" "issn" => "00107824" ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0305" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:1 [ "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "A. Pastor-Clerigues" 1 => "E. Martí-Bonmartí" 2 => "J. Milara" 3 => "P. Almudever" 4 => "J. Cortijo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0115404" "Revista" => array:5 [ "tituloSerie" => "PLoS ONE" "fecha" => "2014" "volumen" => "9" "paginaInicial" => "e115404" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25502575" "web" => "Medline" ] ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0310" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Emulsión lipídica exclusiva de ácidos grasos omega-3 (Omegaven<span class="elsevierStyleSup">®</span>) en el tratamiento de la hepatopatía asociada a nutrición parenteral: a propósito de un caso" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A. Zugasti urillo" 1 => "E. Petrina Jáuregui" 2 => "J. Elizondo Armendáriz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.endonu.2015.03.002" "Revista" => array:6 [ "tituloSerie" => "Endocrinol Nutr" "fecha" => "2015" "volumen" => "62" "paginaInicial" => "294" "paginaFinal" => "296" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25900301" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/21735093/0000006200000006/v2_201802120922/S2173509315000835/v2_201802120922/en/main.assets" "Apartado" => array:4 [ "identificador" => "8670" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Review article" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/21735093/0000006200000006/v2_201802120922/S2173509315000835/v2_201802120922/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2173509315000835?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 October | 113 | 19 | 132 |
2024 September | 241 | 41 | 282 |
2024 August | 195 | 37 | 232 |
2024 July | 223 | 22 | 245 |
2024 June | 254 | 23 | 277 |
2024 May | 237 | 26 | 263 |
2024 April | 256 | 24 | 280 |
2024 March | 243 | 28 | 271 |
2024 February | 275 | 34 | 309 |
2024 January | 272 | 30 | 302 |
2023 December | 200 | 23 | 223 |
2023 November | 264 | 23 | 287 |
2023 October | 255 | 28 | 283 |
2023 September | 194 | 27 | 221 |
2023 August | 119 | 18 | 137 |
2023 July | 126 | 18 | 144 |
2023 June | 119 | 19 | 138 |
2023 May | 172 | 16 | 188 |
2023 April | 135 | 9 | 144 |
2023 March | 127 | 30 | 157 |
2023 February | 136 | 12 | 148 |
2023 January | 129 | 24 | 153 |
2022 December | 128 | 13 | 141 |
2022 November | 126 | 22 | 148 |
2022 October | 142 | 27 | 169 |
2022 September | 94 | 16 | 110 |
2022 August | 79 | 15 | 94 |
2022 July | 71 | 26 | 97 |
2022 June | 119 | 19 | 138 |
2022 May | 111 | 26 | 137 |
2022 April | 92 | 33 | 125 |
2022 March | 116 | 20 | 136 |
2022 February | 68 | 12 | 80 |
2022 January | 95 | 13 | 108 |
2021 December | 61 | 23 | 84 |
2021 November | 115 | 23 | 138 |
2021 October | 114 | 40 | 154 |
2021 September | 107 | 35 | 142 |
2021 August | 106 | 19 | 125 |
2021 July | 80 | 18 | 98 |
2021 June | 78 | 30 | 108 |
2021 May | 124 | 33 | 157 |
2021 April | 308 | 38 | 346 |
2021 March | 121 | 21 | 142 |
2021 February | 93 | 20 | 113 |
2021 January | 127 | 33 | 160 |
2020 December | 84 | 27 | 111 |
2020 November | 117 | 29 | 146 |
2020 October | 78 | 13 | 91 |
2020 September | 59 | 17 | 76 |
2020 August | 165 | 28 | 193 |
2020 July | 71 | 19 | 90 |
2020 June | 63 | 22 | 85 |
2020 May | 111 | 28 | 139 |
2020 April | 72 | 21 | 93 |
2020 March | 80 | 16 | 96 |
2020 February | 61 | 10 | 71 |
2020 January | 62 | 12 | 74 |
2019 December | 64 | 5 | 69 |
2019 November | 86 | 19 | 105 |
2019 October | 142 | 16 | 158 |
2019 September | 111 | 30 | 141 |
2019 August | 84 | 18 | 102 |
2019 July | 65 | 26 | 91 |
2019 June | 138 | 26 | 164 |
2019 May | 251 | 17 | 268 |
2019 April | 94 | 2 | 96 |
2019 March | 44 | 9 | 53 |
2019 February | 34 | 8 | 42 |
2019 January | 33 | 12 | 45 |
2018 December | 36 | 8 | 44 |
2018 November | 31 | 4 | 35 |
2018 October | 43 | 11 | 54 |
2018 September | 30 | 10 | 40 |
2018 August | 17 | 10 | 27 |
2018 July | 24 | 8 | 32 |
2018 June | 21 | 2 | 23 |
2018 May | 26 | 12 | 38 |
2018 April | 24 | 7 | 31 |
2018 March | 27 | 3 | 30 |
2018 February | 19 | 1 | 20 |
2018 January | 30 | 0 | 30 |
2017 December | 26 | 3 | 29 |
2017 November | 49 | 3 | 52 |
2017 October | 92 | 9 | 101 |
2017 September | 26 | 8 | 34 |
2017 August | 60 | 12 | 72 |
2017 July | 29 | 11 | 40 |
2017 June | 56 | 14 | 70 |
2017 May | 58 | 12 | 70 |
2017 April | 30 | 2 | 32 |
2017 March | 40 | 41 | 81 |
2017 February | 65 | 4 | 69 |
2017 January | 38 | 1 | 39 |
2016 December | 36 | 5 | 41 |
2016 November | 36 | 4 | 40 |
2016 October | 50 | 9 | 59 |
2016 September | 53 | 7 | 60 |
2016 August | 51 | 7 | 58 |
2016 July | 40 | 2 | 42 |
2016 June | 46 | 12 | 58 |
2016 May | 42 | 15 | 57 |
2016 April | 54 | 34 | 88 |
2016 March | 40 | 34 | 74 |
2016 February | 41 | 22 | 63 |
2016 January | 28 | 21 | 49 |
2015 December | 26 | 11 | 37 |
2015 November | 3 | 0 | 3 |
2015 September | 1 | 0 | 1 |
2015 August | 0 | 1 | 1 |
2015 July | 0 | 2 | 2 |